These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26709713)

  • 1. Spinal muscular atrophy with respiratory distress type 1 (SMARD1) Report of a Spanish case with extended clinicopathological follow-up.
    San Millan B; Fernandez JM; Navarro C; Reparaz A; Teijeira S
    Clin Neuropathol; 2016; 35(2):58-65. PubMed ID: 26709713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infantile spinal muscular atrophy with respiratory distress type I presenting without respiratory involvement: Novel mutations and review of the literature.
    Luan X; Huang X; Liu X; Zhou H; Chen S; Cao L
    Brain Dev; 2016 Aug; 38(7):685-9. PubMed ID: 26922252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ultrastructure of peripheral nerve, motor end-plate and skeletal muscle in patients suffering from spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Diers A; Kaczinski M; Grohmann K; Hübner C; Stoltenburg-Didinger G
    Acta Neuropathol; 2005 Sep; 110(3):289-97. PubMed ID: 16025284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
    J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral nerve pathology at fixed stage in spinal muscular atrophy with respiratory distress type 1.
    Ikeda A; Yamashita S; Tsuyusaki Y; Tanaka M; Tanaka Y; Hashiguchi A; Takashima H; Goto T
    Brain Dev; 2018 Feb; 40(2):155-158. PubMed ID: 28899595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cells.
    Jędrzejowska M; Madej-Pilarczyk A; Fidziańska A; Mierzewska H; Pronicka E; Obersztyn E; Gos M; Pronicki M; Kmieć T; Migdał M; Mierzewska-Schmidt M; Walczak-Wojtkowska I; Konopka E; Hausmanowa-Petrusewicz I
    Eur J Paediatr Neurol; 2014 Mar; 18(2):183-92. PubMed ID: 24388491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient with spinal muscular atrophy with respiratory distress type 1 presenting initially with hypertonia.
    Han C; Mai J; Tian T; He Y; Liao J; Wen F; Yi X; Yang Y
    Brain Dev; 2015 May; 37(5):542-5. PubMed ID: 25280635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal Muscular Atrophy with Respiratory Distress
    Type 1: A Novel Variant of IGHMBP2 Gene.
    Saeed M; Fawzy W; Al-Tala S; Magid TA; Ahmed H
    J Coll Physicians Surg Pak; 2021 Dec; 31(12):1494-1496. PubMed ID: 34794294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An atypical phenotype of a patient with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD 1).
    Wu S; Chen T; Li Y; Chen L; Xu Q; Xiao F; Bai Z
    Eur J Med Genet; 2018 Oct; 61(10):602-606. PubMed ID: 29653221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growing up with spinal muscular atrophy with respiratory distress (SMARD1).
    Hamilton MJ; Longman C; O'Hara A; Kirkpatrick M; McWilliam R
    Neuromuscul Disord; 2015 Feb; 25(2):169-71. PubMed ID: 25454169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Genome Sequencing and RNA Analysis Reveals and Characterizes a Deep Intronic Variant in IGHMBP2 in a Patient With Spinal Muscular Atrophy With Respiratory Distress Type 1.
    Bodle EE; Zhu W; Velez-Bartolomei F; Tesi-Rocha A; Liu P; Bernstein JA
    Pediatr Neurol; 2021 Jan; 114():16-20. PubMed ID: 33189025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Grohmann K; Varon R; Stolz P; Schuelke M; Janetzki C; Bertini E; Bushby K; Muntoni F; Ouvrier R; Van Maldergem L; Goemans NM; Lochmüller H; Eichholz S; Adams C; Bosch F; Grattan-Smith P; Navarro C; Neitzel H; Polster T; Topaloğlu H; Steglich C; Guenther UP; Zerres K; Rudnik-Schöneborn S; Hübner C
    Ann Neurol; 2003 Dec; 54(6):719-24. PubMed ID: 14681881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review.
    Porro F; Rinchetti P; Magri F; Riboldi G; Nizzardo M; Simone C; Zanetta C; Faravelli I; Corti S
    J Neurol Sci; 2014 Nov; 346(1-2):35-42. PubMed ID: 25248952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal muscular atrophy with respiratory distress type 1 (SMARD1): a rare cause of hypotonia, diaphragmatic weakness, and respiratory failure in infants.
    Pekuz S; Güzin Y; Sarıtaş S; Kırbıyık Ö; Ünalp A; Yılmaz Ü
    Turk J Pediatr; 2022; 64(2):364-374. PubMed ID: 35611426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Grohmann K; Rossoll W; Kobsar I; Holtmann B; Jablonka S; Wessig C; Stoltenburg-Didinger G; Fischer U; Hübner C; Martini R; Sendtner M
    Hum Mol Genet; 2004 Sep; 13(18):2031-42. PubMed ID: 15269181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One novel and one recurrent mutation in IGHMBP2 gene, causing severe spinal muscular atrophy respiratory distress 1 with onset soon after birth.
    Litvinenko I; Kirov AV; Georgieva R; Todorov T; Malinova Z; Mitev V; Todorova A
    J Child Neurol; 2014 Jun; 29(6):799-802. PubMed ID: 23449687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1.
    Pitt M; Houlden H; Jacobs J; Mok Q; Harding B; Reilly M; Surtees R
    Brain; 2003 Dec; 126(Pt 12):2682-92. PubMed ID: 14506069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural course of infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Eckart M; Guenther UP; Idkowiak J; Varon R; Grolle B; Boffi P; Van Maldergem L; Hübner C; Schuelke M; von Au K
    Pediatrics; 2012 Jan; 129(1):e148-56. PubMed ID: 22157136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent.
    Shababi M; Feng Z; Villalon E; Sibigtroth CM; Osman EY; Miller MR; Williams-Simon PA; Lombardi A; Sass TH; Atkinson AK; Garcia ML; Ko CP; Lorson CL
    Mol Ther; 2016 May; 24(5):855-66. PubMed ID: 26860981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diversity caused by novel IGHMBP2 variants.
    Yuan JH; Hashiguchi A; Yoshimura A; Yaguchi H; Tsuzaki K; Ikeda A; Wada-Isoe K; Ando M; Nakamura T; Higuchi Y; Hiramatsu Y; Okamoto Y; Takashima H
    J Hum Genet; 2017 Jun; 62(6):599-604. PubMed ID: 28202949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.